Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Francesco Palazzo is a leading figure in minimally invasive gastrointestinal surgery, with a primary focus on esophageal and pancreatic diseases. His most impactful work centers on establishing evidence-based standards of care, most notably as a key contributor to the 2021 SAGES guidelines for the surgical treatment of gastroesophageal reflux disease (GERD), a landmark paper with 128 citations that shapes clinical practice worldwide. Dr. Palazzo is also a pioneer in advanced oncologic surgery, as demonstrated by his work on total minimally invasive esophagectomy for esophageal cancer (36 citations), where he has helped define optimal approaches and outcomes. His innovative application of robotic-assisted techniques is further highlighted in his report on the surgical management of growing teratoma syndrome via thoracoscopic resection. Beyond these landmark studies, Dr. Palazzo investigates the physiologic benefits of minimally invasive approaches, such as his research showing that minimally invasive distal pancreatectomy is associated with a decreased postoperative neutrophil-to-lymphocyte ratio, suggesting a reduced inflammatory response. Through these contributions, Dr. Palazzo has established himself as a surgeon-scientist dedicated to advancing patient outcomes through rigorous evidence and technical innovation.